Global Biologics Contract Development and Manufacturing Organization (CDMO) Market 2025-2029

Biologics Contract Development And Manufacturing Organization (CDMO) Market 2025-2029


The biologics contract development and manufacturing organization (CDMO) market is forecasted to grow by USD 16324.6 mn during 2024-2029, accelerating at a CAGR of 13.7% during the forecast period. The report on the biologics contract development and manufacturing organization (CDMO) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by availability of cost-efficient resources in emerging markets, strong research and development pipeline of biologics therapeutics, and growing need to focus on core competencies.

Technavio's biologics contract development and manufacturing organization (CDMO) market is segmented as below:

By Type
  • Mammalian
  • Microbial
By Product Type
  • Biologics
  • Biosimilars
By Geographical Landscape
  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the advent of big data as one of the prime reasons driving the biologics contract development and manufacturing organization (CDMO) market growth during the next few years. Also, strategic alliances and partnerships of cdmo vendors with pharma companies and increasing approvals for new molecules and biosimilars will lead to sizable demand in the market.

The report on the biologics contract development and manufacturing organization (CDMO) market covers the following areas:
  • Biologics Contract Development And Manufacturing Organization (CDMO) Market sizing
  • Biologics Contract Development And Manufacturing Organization (CDMO) Market forecast
  • Biologics Contract Development And Manufacturing Organization (CDMO) Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading biologics contract development and manufacturing organization (CDMO) market vendors that include 3P Biopharmaceuticals, AbbVie Inc., AGC Biologics, Binex Co. Ltd., Boehringer Ingelheim International GmbH, Bora Pharmaceuticals, Catalent Inc., Evonik Industries AG, FUJIFILM Corp., Grifols SA, J RETTENMAIER and SOHNE GmbH and Co KG, JSR Corp., Kemwell Biopharma Pvt. Ltd., Lonza Group Ltd., Novartis AG, Rentschler Biopharma SE, Samsung Electronics Co. Ltd., Shenzhen Hepalink Pharmaceutical Co. Ltd., Toyobo Co. Ltd., and WuXi Biologics Cayman Inc.. Also, the biologics contract development and manufacturing organization (CDMO) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.


1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Market Segmentation by Product Type
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Global - Market size and forecast 2024-2029 ($ million)
Data Table on Global - Market size and forecast 2024-2029 ($ million)
Chart on Global Market: Year-over-year growth 2024-2029 (%)
Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Global Biologics Contract Development And Manufacturing Organization (CDMO) Market 2019 - 2023
Historic Market Size - Data Table on Global Biologics Contract Development And Manufacturing Organization (CDMO) Market 2019 - 2023 ($ million)
5.2 Type segment analysis 2019 - 2023
Historic Market Size - Type Segment 2019 - 2023 ($ million)
5.3 Product Type segment analysis 2019 - 2023
Historic Market Size - Product Type Segment 2019 - 2023 ($ million)
5.4 Geography segment analysis 2019 - 2023
Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.5 Country segment analysis 2019 - 2023
Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
6.1 Impact of AI on the Global Biologics Contract Development and Manufacturing Organization (CDMO) Market
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Type
8.1 Market segments
Chart on Type - Market share 2024-2029 (%)
Data Table on Type - Market share 2024-2029 (%)
8.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
8.3 Mammalian - Market size and forecast 2024-2029
Chart on Mammalian - Market size and forecast 2024-2029 ($ million)
Data Table on Mammalian - Market size and forecast 2024-2029 ($ million)
Chart on Mammalian - Year-over-year growth 2024-2029 (%)
Data Table on Mammalian - Year-over-year growth 2024-2029 (%)
8.4 Microbial - Market size and forecast 2024-2029
Chart on Microbial - Market size and forecast 2024-2029 ($ million)
Data Table on Microbial - Market size and forecast 2024-2029 ($ million)
Chart on Microbial - Year-over-year growth 2024-2029 (%)
Data Table on Microbial - Year-over-year growth 2024-2029 (%)
8.5 Market opportunity by Type
Market opportunity by Type ($ million)
Data Table on Market opportunity by Type ($ million)
9 Market Segmentation by Product Type
9.1 Market segments
Chart on Product Type - Market share 2024-2029 (%)
Data Table on Product Type - Market share 2024-2029 (%)
9.2 Comparison by Product Type
Chart on Comparison by Product Type
Data Table on Comparison by Product Type
9.3 Biologics - Market size and forecast 2024-2029
Chart on Biologics - Market size and forecast 2024-2029 ($ million)
Data Table on Biologics - Market size and forecast 2024-2029 ($ million)
Chart on Biologics - Year-over-year growth 2024-2029 (%)
Data Table on Biologics - Year-over-year growth 2024-2029 (%)
9.4 Biosimilars - Market size and forecast 2024-2029
Chart on Biosimilars - Market size and forecast 2024-2029 ($ million)
Data Table on Biosimilars - Market size and forecast 2024-2029 ($ million)
Chart on Biosimilars - Year-over-year growth 2024-2029 (%)
Data Table on Biosimilars - Year-over-year growth 2024-2029 (%)
9.5 Market opportunity by Product Type
Market opportunity by Product Type ($ million)
Data Table on Market opportunity by Product Type ($ million)
10 Customer Landscape
10.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
11 Geographic Landscape
11.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2024-2029 (%)
Data Table on Market share By Geographical Landscape 2024-2029 (%)
11.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
11.3 North America - Market size and forecast 2024-2029
Chart on North America - Market size and forecast 2024-2029 ($ million)
Data Table on North America - Market size and forecast 2024-2029 ($ million)
Chart on North America - Year-over-year growth 2024-2029 (%)
Data Table on North America - Year-over-year growth 2024-2029 (%)
11.4 Europe - Market size and forecast 2024-2029
Chart on Europe - Market size and forecast 2024-2029 ($ million)
Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Chart on Europe - Year-over-year growth 2024-2029 (%)
Data Table on Europe - Year-over-year growth 2024-2029 (%)
11.5 Asia - Market size and forecast 2024-2029
Chart on Asia - Market size and forecast 2024-2029 ($ million)
Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Chart on Asia - Year-over-year growth 2024-2029 (%)
Data Table on Asia - Year-over-year growth 2024-2029 (%)
11.6 Rest of World (ROW) - Market size and forecast 2024-2029
Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
11.7 US - Market size and forecast 2024-2029
Chart on US - Market size and forecast 2024-2029 ($ million)
Data Table on US - Market size and forecast 2024-2029 ($ million)
Chart on US - Year-over-year growth 2024-2029 (%)
Data Table on US - Year-over-year growth 2024-2029 (%)
11.8 Germany - Market size and forecast 2024-2029
Chart on Germany - Market size and forecast 2024-2029 ($ million)
Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Chart on Germany - Year-over-year growth 2024-2029 (%)
Data Table on Germany - Year-over-year growth 2024-2029 (%)
11.9 Canada - Market size and forecast 2024-2029
Chart on Canada - Market size and forecast 2024-2029 ($ million)
Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Chart on Canada - Year-over-year growth 2024-2029 (%)
Data Table on Canada - Year-over-year growth 2024-2029 (%)
11.10 France - Market size and forecast 2024-2029
Chart on France - Market size and forecast 2024-2029 ($ million)
Data Table on France - Market size and forecast 2024-2029 ($ million)
Chart on France - Year-over-year growth 2024-2029 (%)
Data Table on France - Year-over-year growth 2024-2029 (%)
11.11 China - Market size and forecast 2024-2029
Chart on China - Market size and forecast 2024-2029 ($ million)
Data Table on China - Market size and forecast 2024-2029 ($ million)
Chart on China - Year-over-year growth 2024-2029 (%)
Data Table on China - Year-over-year growth 2024-2029 (%)
11.12 UK - Market size and forecast 2024-2029
Chart on UK - Market size and forecast 2024-2029 ($ million)
Data Table on UK - Market size and forecast 2024-2029 ($ million)
Chart on UK - Year-over-year growth 2024-2029 (%)
Data Table on UK - Year-over-year growth 2024-2029 (%)
11.13 Japan - Market size and forecast 2024-2029
Chart on Japan - Market size and forecast 2024-2029 ($ million)
Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Chart on Japan - Year-over-year growth 2024-2029 (%)
Data Table on Japan - Year-over-year growth 2024-2029 (%)
11.14 Italy - Market size and forecast 2024-2029
Chart on Italy - Market size and forecast 2024-2029 ($ million)
Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Chart on Italy - Year-over-year growth 2024-2029 (%)
Data Table on Italy - Year-over-year growth 2024-2029 (%)
11.15 India - Market size and forecast 2024-2029
Chart on India - Market size and forecast 2024-2029 ($ million)
Data Table on India - Market size and forecast 2024-2029 ($ million)
Chart on India - Year-over-year growth 2024-2029 (%)
Data Table on India - Year-over-year growth 2024-2029 (%)
11.16 South Korea - Market size and forecast 2024-2029
Chart on South Korea - Market size and forecast 2024-2029 ($ million)
Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
Chart on South Korea - Year-over-year growth 2024-2029 (%)
Data Table on South Korea - Year-over-year growth 2024-2029 (%)
11.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
12 Drivers, Challenges, and Opportunity/Restraints
12.1 Market drivers
12.2 Market challenges
12.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
12.4 Market opportunities/restraints
13 Competitive Landscape
13.1 Overview
13.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
13.3 Landscape disruption
Overview on factors of disruption
13.4 Industry risks
Impact of key risks on business
14 Competitive Analysis
14.1 Companies profiled
Companies covered
14.2 Company ranking index
Company ranking index
14.3 Market positioning of companies
Matrix on companies position and classification
14.4 AbbVie Inc.
AbbVie Inc. - Overview
AbbVie Inc. - Product / Service
AbbVie Inc. - Key news
AbbVie Inc. - Key offerings
SWOT
14.5 Binex Co. Ltd.
Binex Co. Ltd. - Overview
Binex Co. Ltd. - Product / Service
Binex Co. Ltd. - Key offerings
SWOT
14.6 Boehringer Ingelheim International GmbH
Boehringer Ingelheim International GmbH - Overview
Boehringer Ingelheim International GmbH - Product / Service
Boehringer Ingelheim International GmbH - Key news
Boehringer Ingelheim International GmbH - Key offerings
SWOT
14.7 Bora Pharmaceuticals
Bora Pharmaceuticals - Overview
Bora Pharmaceuticals - Product / Service
Bora Pharmaceuticals - Key offerings
SWOT
14.8 Catalent Inc.
Catalent Inc. - Overview
Catalent Inc. - Business segments
Catalent Inc. - Key offerings
Catalent Inc. - Segment focus
SWOT
14.9 Evonik Industries AG
Evonik Industries AG - Overview
Evonik Industries AG - Business segments
Evonik Industries AG - Key news
Evonik Industries AG - Key offerings
Evonik Industries AG - Segment focus
SWOT
14.10 FUJIFILM Corp.
FUJIFILM Corp. - Overview
FUJIFILM Corp. - Business segments
FUJIFILM Corp. - Key news
FUJIFILM Corp. - Key offerings
FUJIFILM Corp. - Segment focus
SWOT
14.11 Grifols SA
Grifols SA - Overview
Grifols SA - Business segments
Grifols SA - Key news
Grifols SA - Key offerings
Grifols SA - Segment focus
SWOT
14.12 J RETTENMAIER and SOHNE GmbH and Co KG
J RETTENMAIER and SOHNE GmbH and Co KG - Overview
J RETTENMAIER and SOHNE GmbH and Co KG - Product / Service
J RETTENMAIER and SOHNE GmbH and Co KG - Key offerings
SWOT
14.13 Lonza Group Ltd.
Lonza Group Ltd. - Overview
Lonza Group Ltd. - Business segments
Lonza Group Ltd. - Key news
Lonza Group Ltd. - Key offerings
Lonza Group Ltd. - Segment focus
SWOT
14.14 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
SWOT
14.15 Rentschler Biopharma SE
Rentschler Biopharma SE - Overview
Rentschler Biopharma SE - Product / Service
Rentschler Biopharma SE - Key offerings
SWOT
14.16 Samsung Electronics Co. Ltd.
Samsung Electronics Co. Ltd. - Overview
Samsung Electronics Co. Ltd. - Business segments
Samsung Electronics Co. Ltd. - Key news
Samsung Electronics Co. Ltd. - Key offerings
Samsung Electronics Co. Ltd. - Segment focus
SWOT
14.17 Toyobo Co. Ltd.
Toyobo Co. Ltd. - Overview
Toyobo Co. Ltd. - Business segments
Toyobo Co. Ltd. - Key news
Toyobo Co. Ltd. - Key offerings
Toyobo Co. Ltd. - Segment focus
SWOT
14.18 WuXi Biologics Cayman Inc.
WuXi Biologics Cayman Inc. - Overview
WuXi Biologics Cayman Inc. - Product / Service
WuXi Biologics Cayman Inc. - Key offerings
SWOT
15 Appendix
15.1 Scope of the report
15.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
15.3 Currency conversion rates for US$
Currency conversion rates for US$
15.4 Research methodology
Research methodology
15.5 Data procurement
Information sources
15.6 Data validation
Data validation
15.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
15.8 Data synthesis
Data synthesis
15.9 360 degree market analysis
360 degree market analysis
15.10 List of abbreviations
List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Product Type
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits11: Overview on criticality of inputs and factors of differentiation
Exhibits12: Overview on factors of disruption
Exhibits13: Impact of drivers and challenges in 2024 and 2029
Exhibits14: Parent Market
Exhibits15: Data Table on - Parent Market
Exhibits16: Market characteristics analysis
Exhibits17: Value chain analysis
Exhibits18: Offerings of companies included in the market definition
Exhibits19: Market segments
Exhibits20: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits21: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits22: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits23: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits24: Historic Market Size - Data Table on Global Biologics Contract Development And Manufacturing Organization (CDMO) Market 2019 - 2023 ($ million)
Exhibits25: Historic Market Size - Type Segment 2019 - 2023 ($ million)
Exhibits26: Historic Market Size - Product Type Segment 2019 - 2023 ($ million)
Exhibits27: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits28: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits29: Five forces analysis - Comparison between 2024 and 2029
Exhibits30: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits31: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits32: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits33: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits34: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits35: Chart on Market condition - Five forces 2024 and 2029
Exhibits36: Chart on Type - Market share 2024-2029 (%)
Exhibits37: Data Table on Type - Market share 2024-2029 (%)
Exhibits38: Chart on Comparison by Type
Exhibits39: Data Table on Comparison by Type
Exhibits40: Chart on Mammalian - Market size and forecast 2024-2029 ($ million)
Exhibits41: Data Table on Mammalian - Market size and forecast 2024-2029 ($ million)
Exhibits42: Chart on Mammalian - Year-over-year growth 2024-2029 (%)
Exhibits43: Data Table on Mammalian - Year-over-year growth 2024-2029 (%)
Exhibits44: Chart on Microbial - Market size and forecast 2024-2029 ($ million)
Exhibits45: Data Table on Microbial - Market size and forecast 2024-2029 ($ million)
Exhibits46: Chart on Microbial - Year-over-year growth 2024-2029 (%)
Exhibits47: Data Table on Microbial - Year-over-year growth 2024-2029 (%)
Exhibits48: Market opportunity by Type ($ million)
Exhibits49: Data Table on Market opportunity by Type ($ million)
Exhibits50: Chart on Product Type - Market share 2024-2029 (%)
Exhibits51: Data Table on Product Type - Market share 2024-2029 (%)
Exhibits52: Chart on Comparison by Product Type
Exhibits53: Data Table on Comparison by Product Type
Exhibits54: Chart on Biologics - Market size and forecast 2024-2029 ($ million)
Exhibits55: Data Table on Biologics - Market size and forecast 2024-2029 ($ million)
Exhibits56: Chart on Biologics - Year-over-year growth 2024-2029 (%)
Exhibits57: Data Table on Biologics - Year-over-year growth 2024-2029 (%)
Exhibits58: Chart on Biosimilars - Market size and forecast 2024-2029 ($ million)
Exhibits59: Data Table on Biosimilars - Market size and forecast 2024-2029 ($ million)
Exhibits60: Chart on Biosimilars - Year-over-year growth 2024-2029 (%)
Exhibits61: Data Table on Biosimilars - Year-over-year growth 2024-2029 (%)
Exhibits62: Market opportunity by Product Type ($ million)
Exhibits63: Data Table on Market opportunity by Product Type ($ million)
Exhibits64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits65: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits66: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits67: Chart on Geographic comparison
Exhibits68: Data Table on Geographic comparison
Exhibits69: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits70: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits71: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits72: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits73: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits74: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits75: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits76: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits77: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits78: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits79: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits80: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits81: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits82: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits83: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits84: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits85: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits86: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits87: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits88: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits89: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits90: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits91: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits92: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits93: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits94: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits95: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits96: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits97: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibits98: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibits99: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits100: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits101: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits102: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits103: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits104: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits105: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibits106: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibits107: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits108: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits109: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits110: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits111: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits112: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits113: Chart on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits114: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits115: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibits116: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibits117: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibits118: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibits119: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits120: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits121: Chart on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibits122: Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibits123: Chart on South Korea - Year-over-year growth 2024-2029 (%)
Exhibits124: Data Table on South Korea - Year-over-year growth 2024-2029 (%)
Exhibits125: Market opportunity By Geographical Landscape ($ million)
Exhibits126: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits127: Impact of drivers and challenges in 2024 and 2029
Exhibits128: Overview on criticality of inputs and factors of differentiation
Exhibits129: Overview on factors of disruption
Exhibits130: Impact of key risks on business
Exhibits131: Companies covered
Exhibits132: Company ranking index
Exhibits133: Matrix on companies position and classification
Exhibits134: AbbVie Inc. - Overview
Exhibits135: AbbVie Inc. - Product / Service
Exhibits136: AbbVie Inc. - Key news
Exhibits137: AbbVie Inc. - Key offerings
Exhibits138: SWOT
Exhibits139: Binex Co. Ltd. - Overview
Exhibits140: Binex Co. Ltd. - Product / Service
Exhibits141: Binex Co. Ltd. - Key offerings
Exhibits142: SWOT
Exhibits143: Boehringer Ingelheim International GmbH - Overview
Exhibits144: Boehringer Ingelheim International GmbH - Product / Service
Exhibits145: Boehringer Ingelheim International GmbH - Key news
Exhibits146: Boehringer Ingelheim International GmbH - Key offerings
Exhibits147: SWOT
Exhibits148: Bora Pharmaceuticals - Overview
Exhibits149: Bora Pharmaceuticals - Product / Service
Exhibits150: Bora Pharmaceuticals - Key offerings
Exhibits151: SWOT
Exhibits152: Catalent Inc. - Overview
Exhibits153: Catalent Inc. - Business segments
Exhibits154: Catalent Inc. - Key offerings
Exhibits155: Catalent Inc. - Segment focus
Exhibits156: SWOT
Exhibits157: Evonik Industries AG - Overview
Exhibits158: Evonik Industries AG - Business segments
Exhibits159: Evonik Industries AG - Key news
Exhibits160: Evonik Industries AG - Key offerings
Exhibits161: Evonik Industries AG - Segment focus
Exhibits162: SWOT
Exhibits163: FUJIFILM Corp. - Overview
Exhibits164: FUJIFILM Corp. - Business segments
Exhibits165: FUJIFILM Corp. - Key news
Exhibits166: FUJIFILM Corp. - Key offerings
Exhibits167: FUJIFILM Corp. - Segment focus
Exhibits168: SWOT
Exhibits169: Grifols SA - Overview
Exhibits170: Grifols SA - Business segments
Exhibits171: Grifols SA - Key news
Exhibits172: Grifols SA - Key offerings
Exhibits173: Grifols SA - Segment focus
Exhibits174: SWOT
Exhibits175: J RETTENMAIER and SOHNE GmbH and Co KG - Overview
Exhibits176: J RETTENMAIER and SOHNE GmbH and Co KG - Product / Service
Exhibits177: J RETTENMAIER and SOHNE GmbH and Co KG - Key offerings
Exhibits178: SWOT
Exhibits179: Lonza Group Ltd. - Overview
Exhibits180: Lonza Group Ltd. - Business segments
Exhibits181: Lonza Group Ltd. - Key news
Exhibits182: Lonza Group Ltd. - Key offerings
Exhibits183: Lonza Group Ltd. - Segment focus
Exhibits184: SWOT
Exhibits185: Novartis AG - Overview
Exhibits186: Novartis AG - Business segments
Exhibits187: Novartis AG - Key news
Exhibits188: Novartis AG - Key offerings
Exhibits189: Novartis AG - Segment focus
Exhibits190: SWOT
Exhibits191: Rentschler Biopharma SE - Overview
Exhibits192: Rentschler Biopharma SE - Product / Service
Exhibits193: Rentschler Biopharma SE - Key offerings
Exhibits194: SWOT
Exhibits195: Samsung Electronics Co. Ltd. - Overview
Exhibits196: Samsung Electronics Co. Ltd. - Business segments
Exhibits197: Samsung Electronics Co. Ltd. - Key news
Exhibits198: Samsung Electronics Co. Ltd. - Key offerings
Exhibits199: Samsung Electronics Co. Ltd. - Segment focus
Exhibits200: SWOT
Exhibits201: Toyobo Co. Ltd. - Overview
Exhibits202: Toyobo Co. Ltd. - Business segments
Exhibits203: Toyobo Co. Ltd. - Key news
Exhibits204: Toyobo Co. Ltd. - Key offerings
Exhibits205: Toyobo Co. Ltd. - Segment focus
Exhibits206: SWOT
Exhibits207: WuXi Biologics Cayman Inc. - Overview
Exhibits208: WuXi Biologics Cayman Inc. - Product / Service
Exhibits209: WuXi Biologics Cayman Inc. - Key offerings
Exhibits210: SWOT
Exhibits211: Inclusions checklist
Exhibits212: Exclusions checklist
Exhibits213: Currency conversion rates for US$
Exhibits214: Research methodology
Exhibits215: Information sources
Exhibits216: Data validation
Exhibits217: Validation techniques employed for market sizing
Exhibits218: Data synthesis
Exhibits219: 360 degree market analysis
Exhibits220: List of abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings